Breaking News

BREAKING: States Can Limit Providers’ Use of 340B Drugs for Medicaid Patients, CMS Says

BREAKING: States Can Limit Providers’ Use of 340B Drugs for Medicaid Patients, CMS Says

The Centers for Medicare & Medicaid Services released policy guidance yesterday outlining “best practices” states should consider for avoiding duplicate Medicaid rebates and 340B discounts on the same covered outpatient drugs.

Hospital group 340B Health said in a statement that while it strongly supports some of the options that CMS described, it is “extremely troubled by the inclusion of language that would allow states to limit the ability of some or all 340B hospitals and contract pharmacies to use 340B purchased drugs for Medicaid beneficiaries. Allowing such an opt-out would undermine the very purpose of 340B and potentially damage safety-net hospitals’ ability to care for patients with low incomes.”

BREAKING: States Can Limit Providers’ Use of 340B Drugs for Medicaid Patients, CMS Says The Centers for Medicare & Medicaid Services released policy guidance yesterday outlining “best practices” states should consider for avoiding duplicate Medicaid rebates and 340B discounts on...

Please Login or Become a Paid Subscriber to View this Content

If you are already a paid subscriber, please follow the steps below.
If you are not yet a paid subscriber, please Subscribe now.
For questions about subscriptions or technical assistance, please contact Reshma Eggleston at reshma.eggleston@340breport.com.
« Read Previous Read Next »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
×

*Sign up for news summaries and alerts from 340B Report